EMAIL US AT info@crenc.org

CALL US NOW +237 222 315 567

TAKE COURSES

MENUMENU

Home
Services
Articles & Research
NEWS
PROJECTS
ABOUT
JOBS
Mail

MENU

Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.

Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.

June 26, 2026
CRENC Admin
closed

Comments are closed.

Recent Posts

Outcomes of the Central Africa-IeDEA Regional Meeting, 1- 2 April 2024, Douala, Cameroon
CRENC-IeDEA team attends Population Health training in Kigali
Appels à candidatures
Training of IeDEA staff at the Limbe Regional Hospital Site
The 10 Golden Rules for Health Staff Against COVID-19

Categories

EDUCATION
GCHF
IeDEA
NEWS
PARTNERSHIPS
PROJECTS
TRAINING

TAGS

Bamenda Regional Hospital Cameroon Cervical Cancer Clinical Research CRENC Fellows CRENC Projects CREOLE Diabetes Domin Ekaney Douala General Hospital Dr. Sih Colette Dzudie Anastase Headache Heart Failure Hypertension IeDEA INVICTUS ISCEP Jamot Hospital Yaounde Limbe Regional Hospital PASCAR Projects Research Monitoring Research Training SANOFI SCC SICARD

NEWSLETTER SIGN-UP

Enter your email to get the latest updates from CRENC

Email Address

First Name

Prof. ANASTASE DZUDIE

"Research excellence in low-income countries can be achieved through commitment, the quest for novelty, partnership and trust."

Registration Details

Cameroon Autorisation N° 375/2015/RDA/C19/SAAJP

US Federal Regulation Registration (NIH)

FWA N0: FWA00025245
UEI Number: C3K6KH5MFGQ3
NCAGE N0: SCML4
PIC N0: 906908970

OUR LATEST TWEET

Terms and Conditions

Contact CRENC

📍 Rue 1.354, Nouvelle route Omnisport, P.O Box: 3787, Yaoundé, Cameroon.

📧 info@crenc.org | www.crenc.org  📞 +237 222315567

Copyright © 2025- CRENC. Web Design by ebasone

INTERESTED IN MEDICAL RESEARCH?

Enter your email to receive information about clinical research, online courses and materials to achieve better practice of evidence-based medicine.

Your information will *never* be shared or sold to a 3rd party.